SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Pink who wrote (3986)10/11/1998 9:15:00 PM
From: F. Lynn  Read Replies (1) of 18998
 
But does it need the "expertise?" Isnt this what the partnering is for? I think what ABTX brings to the table is the seed library, an asset which cannot be built from outside. Unlike human genomic samples, which can easily be acquired by anyone interested in sequencing them and developing possible commercial applications from, seed genomics are not walking by the office each and every day.
With the majority of commercial crops grown from a limited number of strains, acquiring the genomic diversity needed for large scale sequencing is possible ONLY with access to a seed library. Apart from a few universities, the only sources for these are distributors.

How much biotech expertise did DeKalb and Pioneer have independent of their partnerships? It was my thought that Monsanto and DuPont did much of the sequencing and testing for them-I could be wrong.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News